Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-10-20
2008-11-04
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S307000, C514S311000, C514S415000, C540S594000, C546S139000, C546S152000, C548S469000
Reexamination Certificate
active
07446103
ABSTRACT:
The present invention relates to novel bicyclic benzamide derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
REFERENCES:
patent: 4916128 (1990-04-01), Jonas et al.
patent: 5496844 (1996-03-01), Inai et al.
patent: 1262475 (2002-12-01), None
patent: 9221476 (1997-08-01), None
patent: WO9534540 (1995-12-01), None
patent: WO9840385 (1998-09-01), None
patent: WO9850363 (1998-11-01), None
patent: WO9850364 (1998-11-01), None
patent: WO0006254 (2000-02-01), None
patent: WO0123374 (2001-04-01), None
patent: WO0166520 (2001-09-01), None
patent: WO0166534 (2001-09-01), None
patent: WO0212190 (2002-02-01), None
patent: WO0224695 (2002-03-01), None
patent: WO02076925 (2002-10-01), None
patent: WO02094788 (2002-11-01), None
patent: 2004026305 (2004-04-01), None
patent: 2004035544 (2004-04-01), None
patent: 2004035556 (2004-04-01), None
patent: 2004037800 (2004-05-01), None
Adock et al., “Substituent Effects of19F Nuclear Magnetic Resonance: Polar and π-Electron Effects”, Aust. J. Chem 29:2571-2581 (1976).
Austin et al., “Novel 2,3,4,5-Tetrahydro-1H-3-benzazepines with High Affinity and Selectivity for the Dopamine3Receptor”, Bioorg Med Chem Lett 10:2553-2555 (2000).
Austin et al., “Design and Synthesis of Novel 2,3-Dihydro-1H-isoindoles with High Affinity and Selectivity for the Dopamine D3Receptor,” Bioorg Med Chem Lett 11:685-688 (2001).
Frankel, Chemische Berichte vol. 33 pp. 2811 (1900).
Giovannini et al., “Effects of histamine H3receptor agonista and antagonists on cognitive performance and scopolamine-induced amnesia,” Behavirural Brain Res. 104:147-155 (1999).
Leurs et al., “Therapeutic potential of histamine H3receptor agonists and antagonists,” TiPS 19:177-183 (May 1998).
Lovenberg et al., “Cloning and Funcational Expression of the Human Histamine H3Receptor,” Molecular Pharmacology 55:1101-1107 (1999).
Onodera and Watanabe, “Histamine H3Antagonists as Potential Therapeutics in the CNS,” ed Leurs and Timmerman, pp. 255-267, Elsevier Science B.V. (1998).
Rice et al., “Synthesis of Fluorinated Derivatives of Benzo[k]fluoranthene and indeno[1,2,3-cd]pyrene and 8,9-Dihydro-8,9-epoxybenzo[k]fluoranthene,” J. Org. Chem 53:1775-1779 (1988).
Schlicker et al., “Modulation of neurotransmitter releaseviahistamine H3heteroreceptors,” Fundam Clin Pharmacol 8:128-137 (1994).
Stokker, “Preparation of 1,2,3.4-Tetrahydroisoquinolines Lacking Electron Donating Groups—An Intramolecular Cyclization Complementary to the Pictet-Spengler Reaction,” Tetrahedron Letters 37(31):5453-5456 (1996).
Walsh et al., “Synthesis and Antiallergy Activity of 4-(Diarylhydroxymethyl)-1-[3-(aryloxy)propyl]piperidines and Structurally Related Compounds,” J. Med. Chem 32:105-118 (1989).
Weinstock et al., “Synthesis and Renal Vasodilator Activity of Some Dopamine Agonist 1-Aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: Halogen and Methyl Analogues of Fenoldopam,” J. Med. Chem 29:2315-2325 (1986).
Best Desmond John
Orlek Barry Sidney
Davis Zinna N
Deppenbrock Bonnie L.
Glaxo Group Limited
LandOfFree
Bicyclic benzamide compound as histamine H3 receptor ligand... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic benzamide compound as histamine H3 receptor ligand..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic benzamide compound as histamine H3 receptor ligand... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4034964